Researchers at Mass General Brigham have validated a polygenic risk score that estimates inherited risk for eight cardiovascular conditions, offering a more comprehensive prevention tool. The test, ...

Interpreting genomic test results for cancer care remains a significant challenge, with variability in turnaround times, reporting standards, and clinical utility impacting patient outcomes. As the ...

The tool uses a "polygenic risk score" (PRS) that combines information from hundreds of thousands of common genetic variants across the genome. This integrated report is designed to highlight hidden c ...

Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis and treatment, according to a new study. A baby's genome ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

A genomic test for successfully predicting whether cancer will resist common types of chemotherapy has been developed. Cancer Research UK (CRUK) funded scientists at the University of Cambridge (UK), ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

For years, genetic testing has been treated as something rare and exceptional—a highly specialized tool ordered only by ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

A test that combines clinicopathologic factors and a tumor’s gene expression profile (CP-GEP) reliably identified patients with a less than 10% risk for a positive sentinel lymph node biopsy — though ...